小鼠模型市场规模、份额及成长分析（依模型类型、技术、应用、最终用户及地区划分）－2026-2033年产业预测

全球小鼠模型市场规模预计在 2024 年达到 17.1 亿美元，从 2025 年的 18.2 亿美元成长到 2033 年的 30.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 6.6%。

全球小鼠模型市场的成长主要受癌症、糖尿病和心血管疾病等慢性疾病发生率上升的驱动。随着全球医疗体係日益重视早期检测和创新疗法，小鼠因其在遗传、生物学和行为学上与人类的相似性，在临床前试验中扮演越来越重要的角色。为加速药物研发而进行的大量研发投入进一步提升了对这些先进研究模型的需求。此外，基因工程技术的快速发展，特别是CRISPR-Cas9技术的进步，提高了建构高精度基因转殖小鼠和基因敲除小鼠的能力。这些进步提高了临床前试验的准确性，减少了试验失败，进一步强化了基因工程小鼠在生物医学研究和治疗方法开发中的关键作用。

全球小鼠模型市场驱动因素

慢性疾病（包括癌症、糖尿病和心血管疾病）的日益普及是全球小鼠模型市场扩张的主要驱动力。这些模型在理解疾病的潜在机制方面发挥关键作用，对于测试和评估新型治疗性介入至关重要。它们在药物研发过程中的重要性不容忽视，因为它们有助于快速开发创新治疗方法，以满足日益增长的有效医疗保健解决方案的需求。随着研究人员继续依赖小鼠模型为医学研究做出宝贵贡献，预计这些重要工具的市场将继续保持成长势头。

限制全球小鼠模型市场的因素

全球小鼠模型市场面临许多限制因素，其中最主要的是实验室小鼠的繁殖、饲养和保育成本高。专业设施、合格人员以及严格的伦理准则要求显着增加了营运成本。这种经济负担阻碍了小规模研究机构进入市场，并减缓了市场的整体成长，尤其是在新兴地区。这些因素共同限制了关键资源和技术的获取，最终影响了依赖小鼠模型进行各类科学研究的倡议的进展与拓展。

全球滑鼠模型市场趋势

全球小鼠模型市场正呈现出一个显着的趋势，即製药和生物技术公司越来越多地采用人源化和基因转殖小鼠模型。这项转变的驱动力在于需要更精确地模拟人类疾病状态，以显着提高临床前试验的预测准确性。随着企业寻求改善药物研发流程并降低临床试验失败率，对先进小鼠模型的需求也不断增长。这一趋势反映了更广泛的调查方法改善需求，最终将人源化和基因转殖小鼠模型确立为推动创新治疗方法和优化整个医疗保健领域开发成果的关键工具。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

全球小鼠模型市场规模（按模型类型和复合年增长率划分）（2026-2033 年）

• 近交系小鼠
• 非近交系小鼠
• 基因转殖小鼠（GEM）
• 杂交/共基因小鼠

全球小鼠模型市场规模（依技术及复合年增长率划分）（2026-2033 年）

• CRISPR/基因编辑
• 胚胎干细胞注射
• 显微注射/核移植
• 传统繁殖和重新引入

全球小鼠模型市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 药物发现与开发
• 疾病模式（肿瘤学、免疫学、神经病学、代谢学）
• 毒理学与安全药理学
• 个人化医疗/转化研究

全球滑鼠模型市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 製药和生物技术公司
• 学术和研究机构
• 受託研究机构（CRO）
• 政府和监管机构

全球小鼠模型市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Charles River Laboratories
• The Jackson Laboratory
• Taconic Biosciences
• Envigo
• Janvier Labs
• GenOway
• Cyagen Biosciences
• BioCytogen
• InVivo Biosystems
• Ozgene
• Horizon Discovery
• Crown Bioscience
• The Jackson Laboratory for Genomic Medicine
• GenOway SA
• Transgenic Animal Model Technologies（TAMT）
• Wuxi AppTec
• LAB Research Models & Services
• Biocytogen Pharma Technology
• GeneChem Co., Ltd.
• Shanghai Model Organism Center

结论与建议

Global Mice Model Market size was valued at USD 1.71 Billion in 2024 and is poised to grow from USD 1.82 Billion in 2025 to USD 3.03 Billion by 2033, growing at a CAGR of 6.6% during the forecast period (2026-2033).

The Global Mice Model Market is primarily driven by the increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions. As healthcare systems globally focus on early detection and innovative treatments, the reliance on mice for preclinical trials has heightened due to their genetic, biological, and behavioral similarities to humans. This demand for advanced research models is further amplified by significant investments in R&D aimed at expediting drug discovery. Additionally, the rapid evolution of genetic engineering technologies, particularly CRISPR-Cas9, enhances the capability to produce highly precise transgenic and knockout mice. These advancements improve the accuracy of preclinical tests and reduce trial failures, reinforcing genetically engineered mice's essential role in enhancing biomedical research and therapeutic development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mice Model market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mice Model Market Segments Analysis

Global Mice Model Market is segmented by Model Type, Technology, Application, End-User and region. Based on Model Type, the market is segmented into Inbred Mice, Outbred Mice, Genetically Engineered Mice (GEM) and Hybrid / Congenic Mice. Based on Technology, the market is segmented into CRISPR / Gene-Editing, Embryonic Stem Cell Injection, Microinjection / Nuclear Transfer and Traditional Breeding & Rederivation. Based on Application, the market is segmented into Drug Discovery & Development, Disease Modeling (Oncology, Immunology, Neurology, Metabolic), Toxicology & Safety Pharmacology and Personalized / Translational Research. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organisations (CROs) and Government & Regulatory Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mice Model Market

The rising prevalence of chronic illnesses, including cancer, diabetes, and cardiovascular diseases, significantly propels the expansion of the global mice model market. These models play a vital role in understanding the underlying mechanisms of diseases and are indispensable in testing and assessing new therapeutic interventions. Their importance in the drug discovery process cannot be overstated, as they facilitate the rapid development of innovative treatments that address the increasing need for effective healthcare solutions. As researchers continue to rely on mice models for their valuable contributions to medical research, the market for these essential tools is expected to continue its upward trajectory.

Restraints in the Global Mice Model Market

The global mice model market encounters significant limitations due to the elevated expenses associated with the breeding, maintenance, and housing of laboratory mice. The need for specialized facilities, qualified personnel, and adherence to strict ethical guidelines leads to substantial operational costs. This financial burden creates barriers for smaller research institutions, hindering their ability to participate in the market and slowing overall growth, especially in emerging regions. These factors collectively restrict access to essential resources and technologies, ultimately affecting the progress and expansion of research initiatives reliant on mice models for various scientific studies.

Market Trends of the Global Mice Model Market

The Global Mice Model market is experiencing a notable trend towards the increasing adoption of humanized and transgenic mice models among pharmaceutical and biotech companies. This shift is driven by the need for more accurate replication of human disease conditions, which significantly improves the predictive value of preclinical studies. As companies seek to enhance drug discovery processes and minimize clinical trial failures, the demand for sophisticated mice models is escalating. This trend reflects a broader push for precision in research methodologies, ultimately positioning humanized and transgenic models as vital tools in advancing innovative therapeutics and optimizing developmental outcomes across the healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Mice Model Market Size by Model Type & CAGR (2026-2033)

• Market Overview
• Inbred Mice
• Outbred Mice
• Genetically Engineered Mice (GEM)
• Hybrid / Congenic Mice

Global Mice Model Market Size by Technology & CAGR (2026-2033)

• Market Overview
• CRISPR / Gene-Editing
• Embryonic Stem Cell Injection
• Microinjection / Nuclear Transfer
• Traditional Breeding & Rederivation

Global Mice Model Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery & Development
• Disease Modeling (Oncology, Immunology, Neurology, Metabolic)
• Toxicology & Safety Pharmacology
• Personalized / Translational Research

Global Mice Model Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organisations (CROs)
• Government & Regulatory Agencies

Global Mice Model Market Size & CAGR (2026-2033)

• North America (Model Type, Technology, Application, End-User)
  • US
  • Canada
• Europe (Model Type, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Model Type, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Model Type, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Model Type, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Jackson Laboratory
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taconic Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Envigo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janvier Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenOway
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCytogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InVivo Biosystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ozgene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crown Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Jackson Laboratory for Genomic Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenOway SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transgenic Animal Model Technologies (TAMT)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LAB Research Models & Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen Pharma Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneChem Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Model Organism Center
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations